Literature DB >> 6862189

The EOG in unilateral eye disease: injuries.

A Pinckers, P Hardus, B Nabbe.   

Abstract

In unilateral injuries, the tap to the eye by a penetrating foreign body is sufficient to depress the electro-oculogram (EOG). Total recovery is time-consuming. During the recovery period, complications such as siderosis and detachment may arise, acting with predilection on the light-sensitive EOG component. Blunt traumata and possibly surgical opening of the eyeball predominantly decrease the light-insensitive component of the EOG.

Entities:  

Mesh:

Year:  1983        PMID: 6862189     DOI: 10.1007/bf02133878

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  6 in total

1.  Contralateral effects in the electro-oculogram.

Authors:  J M Thijssen; A Pinckers
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

2.  Flat type electro-oculogram (EOG).

Authors:  A Pinckers; J M Thijssen
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

3.  A multipurpose optical system for ophthalmic electrodiagnosis.

Authors:  J M Thijssen; A Pinckers; A J Otto
Journal:  Ophthalmologica       Date:  1974       Impact factor: 3.250

4.  [Prognostic value of ERG and EOG in blunt contusions of eyeball].

Authors:  H Gliem; D E Möller; G Kietzmann
Journal:  Ophthalmologica       Date:  1971       Impact factor: 3.250

5.  [Electroretinogram and electro-oculogram in bulbar contusions].

Authors:  H Gliem
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1965-10-25

6.  Clinical electro-oculography.

Authors:  A Pinckers
Journal:  Acta Ophthalmol (Copenh)       Date:  1979-08
  6 in total
  2 in total

1.  Retinal function immediately after Nd.YAG-laser treatment.

Authors:  F Hendrikse; A Pinckers
Journal:  Int Ophthalmol       Date:  1987-10       Impact factor: 2.031

2.  The electro-oculogram as an aid in the diagnosis of uveal melanoma.

Authors:  H Brink; A Pinckers; A Verbeek
Journal:  Int Ophthalmol       Date:  1989-09       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.